<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0005039'>Hypoxia</z:mp>-inducible factor 1α (HIF-1α) plays a key role in mediating <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell malignant characteristics </plain></SENT>
<SENT sid="1" pm="."><plain>Recent studies have shown that the <z:chebi fb="0" ids="15358">histone</z:chebi> demethylase JMJD2B is a target of HIF-1α, suggesting that <z:chebi fb="0" ids="15358">histone</z:chebi> methylation may be involved in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> during <z:mp ids='MP_0005039'>hypoxia</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>However, little is known about the tumorigenic role of JMJD2B and its association with <z:mp ids='MP_0005039'>hypoxia</z:mp> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, the downstream target genes and the mechanisms by which JMJD2B regulates its target genes in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> during <z:mp ids='MP_0005039'>hypoxia</z:mp> remain to be clarified </plain></SENT>
<SENT sid="4" pm="."><plain>Our results demonstrated that JMJD2B was induced under <z:mp ids='MP_0005039'>hypoxia</z:mp> in an HIF-1α-dependent manner in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="5" pm="."><plain>JMJD2B played an important role in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell proliferation, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, cell cycle arrest and invasion, which could be modulated through upregulation of a subset of <z:mp ids='MP_0005039'>hypoxia</z:mp>-inducible genes expression by decreasing trimethylation of <z:chebi fb="0" ids="15358">histone</z:chebi> H3 lysine 9 on their promoters </plain></SENT>
<SENT sid="6" pm="."><plain>We also showed that JMJD2B was overexpressed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues and positively correlated with expression of the hypoxic marker carbonic anhydrase 9 (CA9), deeper depth of invasion and advanced clinical stages </plain></SENT>
<SENT sid="7" pm="."><plain>Therefore, our findings suggest that JMJD2B may serve as a potential therapeutic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> target </plain></SENT>
</text></document>